The all-in-one platform to find and track your stocks and investments
Discover the features
Statistics
Yield
1.5%
Dividend safety
N/A
Growth score
N/A
Dividend growth last 5 y.
-
Market Cap
8 billion
PE Ratio
19.07 x
Beta (volatility)
1.21
Earnings Per Share
0.27
About
ISIN : US3984382008
engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives.
The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions.
The Bioscience...
Price
Performance Comparison
| GRIFOLS ADR 1/2/EO-50 | |
|---|---|
| 1 year return |
+24 %
|
| 5 years return | - |
Valuation
| Price to Book | Payout ratio | PEG Ratio |
|---|---|---|
| 1.28 | 28 % | 0.24 |
| Price to Sales | Price / FCF | E.V.R. |
|---|---|---|
| 1.95 |
Price–Earnings Ratio History
The Price–Earnings Ratio history is not available for this stock.
Dividend History
Uninter. Dividend
1 years
Frequency
1x / year
Dividends in 2025
August
Dividends in 2024
August
Dividends in 2024
Forward Annual Amount
€0.08
Ex-dividend
8/12/2025
Financials
Year-over-Year growth
Profitability
Health
News
Earnings report announcement
2/24/2026
[Latest] Global Cell Therapy Raw Materials Market Size/Share Worth USD 29.3 Billion by 2035 at a 18.9% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
2/11/2026
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading
2/5/2026
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
1/21/2026
European Equities Traded in the US as American Depositary Receipts Little Changed in Thursday Trading
1/15/2026
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
1/9/2026
Health Care Roundup: Market Talk
1/23/2024
Create a portfolio & add this stock
Add this stock and others to your own virtual portfolio and get personalised information : total annual dividends & total value, sectors breakdown, etc.
Privacy Policy • Terms and Conditions
© Copyright 2020-2026 Epsylia OÜ - All rights reserved
Moning is a platform that does not manage any funds and is purely educational. We do not provide any investment advice.
The data presented comes from different providers and may contain errors. We encourage you to always verify information through other sources.
Any financial investment involves risks including partial or total loss of capital.
The data presented comes from different providers and may contain errors. We encourage you to always verify information through other sources.
Any financial investment involves risks including partial or total loss of capital.